Endospan today announced the presentation of 30-day results from a study evaluating its Nexus aortic arch stent graft system.

Endospan announced 30-day results of the statistical Dissection primary arm from the TRIOMPHE investigational device ...

C, The stent graft is deployed from the middle segment, expanding outward. D, Fully deployed thoracic device. A trilobed balloon is used to inflate the aortic stent graft while allowing continuous ...

Kolkata's IPGMER doctors achieve a first with innovative abdominal stent grafting technique for aortic dissection. Patient recovering well after a successful procedure.

Individuals with descending thoracic or abdominal aortic aneurysms usually do not have symptoms ... X-rays and/or ultrasound imaging are used to check that the graft is properly positioned. The stent ...

Artivion presents new clinical data from NEXUS TRIOMPHE IDE trial at the 105th AATS Annual Meeting: Atlanta Tuesday, May 6, 2025, 13:00 Hrs [IST] Artivion, Inc., a leading cardiac ...

It was reported during the session that the 30-day results from the TRIOMPHE study are promising for aortic arch treatment in Zone 0 with the NEXUS Aortic Arch Stent-Graft System. The study results ...

clinical study evaluating the NEXUS® Aortic Arch Stent-Graft System. The data were presented during the late-breaking trial session at the American Association for Thoracic Surgery (AATS ...

Aortic coarctation is a fatal cardiovascular disease. For Stanford type B aortic coarctation, aortic endovascular isolation (TEVAR) is currently the treatment of choice and is far less invasive than ...

The global branched stent graft market has demonstrated robust growth in recent years, and projections indicate continued expansion in the coming decade. With an estimated market value of USD 361 ...